We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lawmakers Press FDA for Documents Relating to Controversial Opioid Approval
Lawmakers Press FDA for Documents Relating to Controversial Opioid Approval
Congressional Democrats are calling on the FDA to answer “substantive questions” surrounding the agency’s approval of Dsuvia, AcelRx’s sublingual formulation of the powerful opioid sufentanil.